Cerebral metabolism in male patients with schizophrenia who have seriously and dangerously violently offended: A 31P magnetic resonance spectroscopy study

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 70, Issue 4, 2004, Pages 409-411

  Puri, B K ^a   Counsell, S J ^a   Hamilton, G ^a   Bustos, M G ^a,b   Horrobin, D F ^c   Richardson, A J ^d,e   Treasaden, I H ^a,b  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b WEST LONDON MENTAL HEALTH NHS TRUST   (United Kingdom)

^c Laxdale Ltd   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA NUCLEOTIDE TRIPHOSPHATE; GAMMA NUCLEOTIDE TRIPHOSPHATE; MEMBRANE PHOSPHOLIPID; NUCLEOTIDE; UNCLASSIFIED DRUG;

ADULT; ASSAULT; BRAIN METABOLISM; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; ENERGY METABOLISM; HOMICIDE; HUMAN; MALE; OFFENDER; PHOSPHOLIPID METABOLISM; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; VIOLENCE;

EID: 1842453641     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2003.12.017     Document Type: Conference Paper

References (15)

1. D.F. Horrobin, M.S. Manku, H. Hillman, A. Iain, M. Glen, Fatty acid levels in the brains of schizophrenics and normal controls, Biol. Psychiatry 30 (1991) 795-805.
2. J.K. Yao, D.P. Van Kammen, J.A. Welker, Red blood cell membrane dynamics in schizophrenia. II. Fatty acid composition, Schizophr. Res. 13 (1994) 217-226.
3. J.K. Yao, D.P. Van Kammen, J. Gurklis, Red blood cell membrane dynamics in schizophrenia. III. Correlation of fatty acid abnormalities with clinical measures, Schizophr. Res. 13 (1994) 227-232.
4. M. Peet, J. Laugharne, N. Rangarajan, D. Horrobin, G. Reynolds, Depleted red cell membrane essential fatty acids in drug-treated schizophrenic patients, J. Psychiatr. Res. 29 (1995) 227-232.
5. W.F. Gattaz, M. Kollisch, T. Thuren, J.A. Virtanen, P.K. Kinnunen, Increased plasma phospholipase-A2 activity in schizophrenic patients. Reduction after neuroleptic therapy, Biol. Psychiatry 22 (1987) 421-426.
6. W.F. Gattaz, C.V. Hubner, T.J. Nevalainen, T. Thuren, P.K. Kinnunen, Increased serum phospholipase A2 activity in schizophrenia: a replication study, Biol. Psychiatry 28 (1990) 495-501.
7. W.F. Gattaz, A. Schmitt, A. Maras, Increased platelet phospholipase A2 activity in schizophrenia, Schizophr. Res. 16 (1995) 1-6.
8. P.E. Ward, J. Sutherland, E.M. Glen, A.I. Glen, Niacin skin flush in schizophrenia: a preliminary report, Schizophr. Res. 29 (1998) 269-274.
9. B.K. Puri, S.R. Hirsch, T. Easton, A.J. Richardson, A volumetric biochemical niacin flush-based index that noninvasively detects fatty acid deficiency in schizophrenia, Prog. Neuropsychopharmacol. Biol. Psychiatry 26 (2002) 49-52.
10. D.F. Horrobin, A.I. Glen, K. Vaddadi, The membrane hypothesis of schizophrenia, Schizophr. Res. 13 (1994) 195-207.
11. F. Corrigan, R. Gray, A. Strathdee, R. Skinner, A. Van Rhijn, D. Horrobin, Fatty acid analysis of blood from violent offenders, J. Forensic. Psychiatry 5 (1994) 83-91.
12. L. Vanhamme, A. Van Den Boogaart, S. Van Huffel, Improved method for accurate and efficient quantification of MRS data with use of prior knowledge, J. Magn. Reson. 129 (1997) 35-43.
13. A. Naressi, C. Couturier, J.M. Devos, M. Janssen, C. Mangeat, R. de Beer, D. Graveron-Demilly, Java-based graphical user interface for the MRUI quantitation package, J. Magn. Magn. Mater. 12 (2001) 141-152.
14. I.J. Cox, Development and applications of in vivo clinical magnetic resonance spectroscopy, Prog. Biophys. Mol. Biol. 65 (1996) 45-81.
15. H. Fukuzako, Neurochemical investigation of the schizophrenic brain by in vivo phosphorus magnetic resonance spectroscopy, World J. Biol. Psychiatry 2 (2001) 70-82.